2-Methoxyestradiol binding of GPR30 down-regulates angiotensin AT 1 receptor

European Journal of Pharmacology

Volumn 723, Issue 1, 2014, Pages 131-140

  Koganti, Sivaramakrishna ^a   Snyder, Russell ^a   Gumaste, Upendra ^a   Karamyan, Vardan T ^a   Thekkumkara, Thomas ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

2 Methoxyestradiol (2ME2); Angiotensin II; Epidermal growth factor receptor (EGFR); G Protein coupled receptor 30 (GPR30); MAP Kinase

Indexed keywords

2 METHOXYESTRADIOL; ANGIOTENSIN 1 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME PHOSPHORYLATION; HORMONE ACTION; HORMONE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

2-METHOXYESTRADIOL (2ME2); ANGIOTENSIN AT(1) RECEPTOR; ANGIOTENSIN II; EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR); G-PROTEIN COUPLED RECEPTOR 30 (GPR30); MAP-KINASE;

ANIMALS; CELL LINE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; ESTRADIOL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN BINDING; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84891353259     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.064     Document Type: Article

References (58)

1. M.D. Al-Bader, S.A. Malatiali, and Z.B. Redzic Expression of estrogen receptor α and β in rat astrocytes in primary culture: effects of hypoxia and glucose deprivation Physiol. Res. 60 6 2011 951 960
2. L. Albanito, A. Madeo, R. Lappano, A. Vivacqua, V. Rago, A. Carpino, T.I. Oprea, E.R. Prossnitz, A.M. Musti, S. Andò, and M. Maggiolini G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells Cancer Res. 67 4 2007 1859 1866
3. F. Barchiesi, E. Lucchinetti, M. Zaugg, O.O. Ogunshola, M. Wright, M. Meyer, M. Rosselli, S. Schaufelberger, D.G. Gillespie, E.K. Jackson, and R.K. Dubey Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection Hypertension 56 5 2010 964 972
4. N.E. Bhola, and J.R. Grandis Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer Front Biosci. 13 2008 1857 1865
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
6. S. Chakrabarti, and S.T. Davidge G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation PLOS ONE 7 12 2012 e52357
7. A.P. Dantas, and K. Sandberg Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis Circ. Res. 99 3 2006 234 237
8. M. Delbeck, S. Golz, R. Vonk, W. Janssen, T. Hucho, J. Isensee, S. Schäfer, and C. Otto Impaired left-ventricular cardiac function in male GPR30-deficient mice Mol. Med. Rep. 4 1 2011 37 40
9. R.K. Dubey, and E.K. Jackson Potential vascular actions of 2-methoxyestradiol Trends Endocrinol. Metab. 20 8 2009 374 379
10. E.J. Filardo, J.A. Quinn, K.I. Bland, and A.R. Frackelton Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Mol. Endocrinol. 14 10 2000 1649 1660
11. E.J. Filardo, J.A. Quinn, and E. Sabo Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor Steroids 73 9-10 2008 870 873
12. E.J. Filardo, and P. Thomas GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release Trends Endocrinol. Metab. 16 8 2005 362 367
13. E.J. Filardo, and P. Thomas Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology Endocrinology 153 7 2012 2953 2962
14. E.J. Filardo Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer J. Steroid Biochem. Mol. Biol. 80 2 2002 231 238
15. T.M. Finlay, P. Jayanth, S.R. Amith, A. Gilmour, C. Guzzo, K. Gee, R. Beyaert, and M.R. Szewczuk Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9 Glycoconj. J. 27 3 2010 329 348
16. A. Gadducci, N. Biglia, S. Cosio, P. Sismondi, and A.R. Genazzani Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue Gynecol. Endocrinol. 25 12 2009 807 815
17. S.M. Gapstur, M. Morrow, and T.A. Sellers Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study JAMA 281 22 1999 2091 2097
18. A. Gschwind, S. Hart, O.M. Fischer, and A. Ullrich TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells EMBO J. 22 10 2003 2411 2421
19. R.C. Harris, K.A. Munger, K.F. Badr, and K. Takahashi Mediation of renal vascular effects of epidermal growth factor by arachidonate metabolites FASEB J. 4 6 1990 1654 1660
20. T. Holbro, and N.E. Hynes ErbB receptors: directing key signaling networks throughout life Annu. Rev. Pharmacol. Toxicol. 44 2004 195 217
21. L. Kang, X. Zhang, Y. Xie, Y. Tu, D. Wang, Z. Liu, and Z.Y. Wang Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling Mol. Endocrinol. 24 4 2010 709 721
22. S. Koganti, R. Snyder, and T. Thekkumkara Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells Gend. Med. 9 2 2012 76 93
23. G.G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson, and J.A. Gustafsson Cloning of a novel receptor expressed in rat prostate and ovary Proc. Natl. Acad. Sci. USA 93 12 1996 5925 5930
24. A.P. Kumar, G.E. Garcia, and T.J. Slaga 2-Methoxyestradiol blocks cell-cycle progression at G(2)/M phase and inhibits growth of human prostate cancer cells Mol. Carcinog. 31 3 2001 111 124
25. R. Kumar, A. Balhuizen, S. Amisten, I. Lundquist, and A. Salehi Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets Endocrinology 152 7 2011 2568 2579
26. R.K. Kumar, C.C. Chapple, and N. Hunter Improved double immunofluorescence for confocal laser scanning microscopy J. Histochem. Cytochem. 47 9 1999 1213 1218
27. G. Langer, B. Bader, L. Meoli, J. Isensee, M. Delbeck, P.R. Noppinger, and C. Otto A critical review of fundamental controversies in the field of GPR30 research Steroids 75 8-9 2010 603 610
28. Z.L. Li, J.C. Liu, S.B. Liu, X.Q. Li, D.H. Yi, and M.G. Zhao Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus PLOS ONE 7 6 2012 e38787
29. S.H. Lindsey, J.A. Cohen, K.B. Brosnihan, P.E. Gallagher, and M.C. Chappell Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats Endocrinology 150 8 2009 3753 3758
30. L. Lisabeth, and C. Bushnell Stroke risk in women: the role of menopause and hormone therapy Lancet. Neurol. 11 1 2012 82 91
31. X. Liu, P. Zhu, K.W. Sham, J.M. Yuen, C. Xie, Y. Zhang, Y. Liu, S. Li, X. Huang, C.H. Cheng, and H. Lin Identification of a membrane estrogen receptor in zebrafish with homology to mammalian GPER and its high expression in early germ cells of the testis Biol. Reprod. 80 6 2009 1253 1261
32. C. Magnusson, J.A. Baron, N. Correia, R. Bergström, H.O. Adami, and I. Persson Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy Int. J. Cancer 81 3 1999 339 344
33. U.E. Mårtensson, S.A. Salehi, S. Windahl, M.F. Gomez, K. Swärd, J. Daszkiewicz-Nilsson, A. Wendt, N. Andersson, P. Hellstrand, P.O. Grände, C. Owman, C.J. Rosen, M.L. Adamo, I. Lundquist, P. Rorsman, B.O. Nilsson, C. Ohlsson, B. Olde, and L.M. Leeb-Lundberg Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice Endocrinology 150 2 2009 687 698
34. C.M. Masi, L.C. Hawkley, and J.T. Cacioppo Serum 2-methoxyestradiol, an estrogen metabolite, is positively associated with serum HDL-C in a population-based sample Lipids 47 1 2012 35 38
35. Y. Matsumoto, K. Kanamoto, K. Kawakubo, H. Aomi, T. Matsumoto, S. Ibayashi, and M. Fujishima Gastroprotective and vasodilatory effects of epidermal growth factor: the role of sensory afferent neurons Am. J. Physiol. Gastrointest Liver Physiol. 280 5 2001 G897 G903
36. S.T. McEwen, S.F. Balus, M.J. Durand, and J.H. Lombard Angiotensin II maintains cerebral vascular relaxation via EGF receptor transactivation and ERK1/2 Am. J. Physiol. Heart Circ. Physiol. 297 4 2009 H1296 H1303
37. M.R. Meyer, E.R. Prossnitz, and M. Barton The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function Vascul. Pharmacol. 55 1-3 2011 17 25
38. A.O. Mueck, and H. Seeger 2-Methoxyestradiol-biology and mechanism of action Steroids 75 10 2010 625 631
39. B.O. Nilsson, B. Olde, and L.M. Leeb-Lundberg G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling Br. J. Pharmacol. 163 6 2011 1131 1139
40. H. Ohtsu, P.J. Dempsey, and S. Eguchi ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors Am. J. Physiol. Cell Physiol. 291 1 2006 C1 10
41. M. Paolillo, and S. Schinelli Therapeutic targeting of g-protein coupled receptor-mediated epidermal growth factor receptor transactivation in human glioma brain tumors Mini. Rev. Med. Chem. 8 13 2008 1418 1428
42. M.R. Parrish, K. Wallace, K.B. Tam Tam, F. Herse, A. Weimer, K. Wenzel, G. Wallukat, L.F. Ray, M. Arany, K. Cockrell, J.N. Martin, R. Dechend, and B. LaMarca Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension Am. J. Hypertens. 24 7 2011 835 840
43. A. Pedram, M. Razandi, and E.R. Levin Nature of functional estrogen receptors at the plasma membrane Mol. Endocrinol. 20 9 2006 1996 2009
44. E. Pimenta Hypertension in women Hypertens. Res. 35 2 2012 148 152
45. V.S. Pribluda, E.R. Gubish Jr, T.M. Lavallee, A. Treston, G.M. Swartz, and S.J. Green 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate Cancer Metastasis Rev. 19 1-2 2000 173 179
46. M. Pupo, A. Pisano, R. Lappano, M.F. Santolla, E.M. De Francesco, S. Abonante, C. Rosano, M. Maggiolini, and A. Bisphenol Induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts Environ. Health Perspect. 120 8 2012 1177 1182
47. X. Qiao, K.R. McConnell, and R.A. Khalil Sex steroids and vascular responses in hypertension and aging Gend. Med. 5 Suppl. A 2008 S46 S64
48. S.E. Rieder, and S.D. Emr J.S. Bonifacino, M. Dasso, J.B. Harford, J. Lippincott-Schwartz, K.M. Yamada, Current Protocols in Cell Biology 1999 John Wiley New York 3.2.36
49. Y.M. Seok, E.J. Jang, O. Reiser, M. Hager, and I.K. Kim 17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner Naunyn Schmiedebergs Arch. Pharmacol. 2012 (JEpub ahead of print)
50. J.D. Sibonga, S. Lotinun, G.L. Evans, V.S. Pribluda, S.J. Green, and R.T. Turner Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat Endocrinology 144 3 2003 785 792
51. T.J. Thekkumkara, R. Cookson, and S.L. Linas Angiotensin (AT1A) receptor-mediated increases in transcellular sodium transport in proximal tubule cells Am. J. Physiol. 274 5 Pt 2 1998 F897 F905
52. P. Thomas, R. Alyea, Y. Pang, C. Peyton, J. Dong, and A.H. Berg Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish Steroids 75 8-9 2010 595 602
53. S.P. Tofovic Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease J. Cardiovasc. Pharmacol. 56 6 2010 696 708
54. P.L. Tuma, and A.L. Hubbard J.S. Bonifacino, M. DAsso, J.B. Harford, J. Lippincott-Schwartz, K.M. Yamada, Current Protocols in Cell Biology 1999 John Wiley New York 3.2.1 3.2.5
55. B.G. Wren The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women Med. J. Aust. 190 6 2009 321 325
56. Y. Yamashita, and M. Shimada The release of EGF domain from EGF-like factors by a specific cleavage enzyme activates the EGFR-MAPK3/1 pathway in both granulosa cells and cumulus cells during the ovulation process J. Reprod. Dev. 58 5 2012 510 514
57. F.L. Yang, K.Q. Hu, X. Wang, Z.M. Liu, Q. Hu, J.F. Li, and H. He Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause Acta Pharmacol. Sin. 32 8 2011 1031 1037
58. Y. Zhou, D. Brigstock, and G.E. Besner Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles Microvasc. Res. 78 1 2009 78 85